Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Q/C TECHNOLOGIES, INC. Director's Dealing 2014

Jan 24, 2014

35313_dirs_2014-01-24_1ed3ad81-4bee-429f-af78-29f506e1d448.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2014-01-23

Reporting Person: AKERS RAYMOND FRANCIS JR (Director, Executive Chairman, Secretary)

More from Q/C TECHNOLOGIES, INC.

Interim / Quarterly Report 2026
May 15
Annual Report 2026
Apr 29
Annual Report 2026
Apr 15
Regulatory Filings 2026
Feb 11
Director's Dealing 2026
Jan 30
Director's Dealing 2026
Jan 30
Regulatory Filings 2026
Jan 23
Regulatory Filings 2025
Dec 9
Regulatory Filings 2025
Dec 1
Regulatory Filings 2025
Dec 1
View all filings →